Page last updated: 2024-10-27

fluorouracil and Deficiency, Vitamin D

fluorouracil has been researched along with Deficiency, Vitamin D in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"Patients with locally advanced breast cancer treated with neoadjuvant chemotherapy are at risk of cancer treatment-induced bone loss and consequently of increased skeletal morbidity."1.38Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. ( Bleuse, JP; Chapelle, A; Jacot, W; Lamy, PJ; Pouderoux, S; Romieu, G; Thezenas, S, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacot, W1
Pouderoux, S1
Thezenas, S1
Chapelle, A1
Bleuse, JP1
Romieu, G1
Lamy, PJ1

Other Studies

1 other study available for fluorouracil and Deficiency, Vitamin D

ArticleYear
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
    Breast cancer research and treatment, 2012, Volume: 134, Issue:2

    Topics: Acid Phosphatase; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and

2012